Shah Nikhil L, Sanda Martin
Henry Ford Health Systems, Vattikuti Urology Institute, Detroit, MI.
Support Cancer Ther. 2004 Jul 1;1(4):230-6. doi: 10.3816/SCT.2004.n.015.
Improvements in detecting and treating prostate cancer account for the need to evaluate strategies for optimizing quality of life (QOL) among survivors of prostate cancer. Several management options are available when prostate cancer is diagnosed at an early stage. However, the optimal treatment for localized prostate cancer is unknown, and reports in the literature are controversial regarding the best treatment modality. In this article, the authors will review the standard therapies used to treat localized prostate cancer and the effects of these therapies on a patient's QOL. Ultimately, the decision of which treatment modality to choose will be a decision based largely on individual patient preferences in concert with his physician and family members, in view of a thorough understanding of the available treatments and the full range of possible treatment-related side effects.
前列腺癌检测与治疗方面的进展，使得有必要对优化前列腺癌幸存者生活质量（QOL）的策略进行评估。前列腺癌早期诊断时，有多种治疗选择。然而，局限性前列腺癌的最佳治疗方法尚不清楚，文献报道中关于最佳治疗方式存在争议。在本文中，作者将回顾用于治疗局限性前列腺癌的标准疗法以及这些疗法对患者生活质量的影响。最终，选择哪种治疗方式很大程度上取决于患者个人偏好，并与医生和家庭成员共同做出决定，这需要全面了解现有治疗方法以及所有可能的治疗相关副作用。
